Effect of alphapinen addition to quadruple therapy for the eradication of Helicobacter pylori gastrointestinal infectious
Phase 3
- Conditions
- Infectious with Helicobacter pylori.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81
- Registration Number
- IRCT20121021011192N15
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Patients who infected with Helicobacter pylori on the basis of doing urease breath test
Obtaining written informed consent
Exclusion Criteria
Patients with previous history of allergy to alphapinen
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication of Helicobacter pylori. Timepoint: 1month after finishing drugs. Method of measurement: Assesing the urease breath test.
- Secondary Outcome Measures
Name Time Method